Atlas Trials

Safety and Effectiveness Study of Allogeneic Umbilical Cord Blood-derived Mesenchymal Stem Cell in Patients With RDEB

Clinical trial NCT04520022 · COMPLETED

Trial details

NCT number
NCT04520022
Sponsor
Gangnam Severance Hospital
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Recessive Dystrophic Epidermolysis Bullosa
Start date
2016-10-13
Primary completion
2020-01-10
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.